Tailored Liposomal Compositions for Specialized Environments

Publication ID: 24-11857680_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Tailored Liposomal Compositions for Specialized Environments,” Published Technical Disclosure No. 24-11857680_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857680_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,680.

Summary of the Inventive Concept

The present invention relates to adapted liposomal compositions of docetaxel for specific operational environments, including high-temperature storage, disaster relief, high-security needs, extreme weather conditions, and emergency medical kits.

Background and Problem Solved

The original patent provided a composition of docetaxel liposomal injection with high drug loading. However, it lacked adaptations for specialized environments, limiting its applicability. The present invention addresses this limitation by introducing tailored liposomal compositions to cater to unique operational requirements.

Detailed Description of the Inventive Concept

The new inventive concept comprises five specialized variations of liposomal compositions: (1) for high-temperature storage, featuring a lyoprotectant to maintain stability above 40°C; (2) for disaster relief, utilizing a solubilizer to facilitate rapid reconstitution; (3) for high-security needs, incorporating a pH adjusting agent to achieve a pH below 3.5; (4) for extreme weather conditions, employing a temperature-controlled container to preserve the composition; and (5) for emergency medical kits, ensuring stability for at least 6 months at room temperature. These adaptations enable the liposomal compositions to perform effectively in diverse environments.

Novelty and Inventive Step

The novelty of the present invention lies in the tailored liposomal compositions, which address specific operational requirements. The inventive step resides in the identification of these unique needs and the development of adapted compositions to cater to them.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the ratio of docetaxel to phospholipids, cholesterol, and lyoprotectants, as well as the use of different solubilizers or pH adjusting agents. Additionally, the inventive concept could be expanded to include other operational environments, such as space exploration or high-altitude settings.

Potential Commercial Applications and Market

The present invention has significant commercial potential in the pharmaceutical industry, particularly in the development of targeted therapies for cancer treatment. The specialized liposomal compositions can cater to diverse market segments, including disaster relief organizations, high-security facilities, and emergency medical services.

CPC Classifications

SectionClassGroup
A A61 A61K9/127
A A61 A61K9/0019
A A61 A61K9/1277
A A61 A61K31/337
A A61 A61K47/24
A A61 A61K47/26
A A61 A61K47/28

Original Patent Information

Patent NumberUS 11,857,680
TitleComposition of docetaxel liposomal injection with high drug loading
Assignee(s)SHILPA MEDICARE LIMITED